AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 88150-75-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 88150-75-8
Also known as: 88150-75-8, Ethyl 4-[2-(1,3-dioxoisoindol-2-yl)ethoxy]-3-oxobutanoate, Ethyl-4(2-phthalimido ethoxy)acetoacetate, Ethyl 4-(2-phthalimidoethoxy)acetoacetate, Mfcd12407176, Ethyl 4-[2-(phthalimido)ethoxy]acetoacetate
Molecular Formula
C16H17NO6
Molecular Weight
319.31  g/mol
InChI Key
RIGKLAOKQFKWNN-UHFFFAOYSA-N

1 2D Structure

CAS 88150-75-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
ethyl 4-[2-(1,3-dioxoisoindol-2-yl)ethoxy]-3-oxobutanoate
2.1.2 InChI
InChI=1S/C16H17NO6/c1-2-23-14(19)9-11(18)10-22-8-7-17-15(20)12-5-3-4-6-13(12)16(17)21/h3-6H,2,7-10H2,1H3
2.1.3 InChI Key
RIGKLAOKQFKWNN-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOC(=O)CC(=O)COCCN1C(=O)C2=CC=CC=C2C1=O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 88150-75-8

2. Ethyl 4-[2-(1,3-dioxoisoindol-2-yl)ethoxy]-3-oxobutanoate

3. Ethyl-4(2-phthalimido Ethoxy)acetoacetate

4. Ethyl 4-(2-phthalimidoethoxy)acetoacetate

5. Mfcd12407176

6. Ethyl 4-[2-(phthalimido)ethoxy]acetoacetate

7. Ethyl 4-(2-(phthalimido)ethoxy)acetoacetate

8. Schembl4985915

9. Dtxsid90431687

10. Rigklaokqfkwnn-uhfffaoysa-n

11. Ethyl4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

12. Bcp33274

13. Ethyl 4-[2-(1,3-dioxo-2-isoindolinyl)ethoxy]-3-oxobutanoate

14. Akos015916097

15. Ac-5611

16. Ds-3729

17. Sb66146

18. Ethyl-4-(2-phthalimidoethoxy)acetoacetate

19. Sy271842

20. Cs-0061613

21. W17210

22. 4-(2-phthalimidylethoxy)acetoacetic Acid Ethyl Ester

23. 4-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-ethoxy]-3-oxo-butyric Acid Ethyl Ester

24. Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy]-3-oxobutanoate

25. Ethyl 4-[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxyl]-3-oxobutanoate

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 319.31 g/mol
Molecular Formula C16H17NO6
XLogP30.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area90
Heavy Atom Count23
Formal Charge0
Complexity465
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Switzerland
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and bus...
DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering growth for businesses in Asia and beyond for over 155 years. DKSH operates in 36 markets, is listed on the SIX Swiss Exchange, employs 33,100 specialists, and generated net sales of CHF 11.1 billion in 2021. It is the leading global distributor of innovative pharma ingredients for pharmaceutical synthesis and formulation. It offers a range of products, ranging from animal care products to packaging materials, intermediates to nutraceuticals, and APIs to excipients.
Flag India
Digital Content Digital Content
14205-39-1
Amlodipine Besylate
"The Company’s product portfolio includes a wide range of products such as Acetyl Intermediates, Specia...
"The Company’s product portfolio includes a wide range of products such as Acetyl Intermediates, Speciality Intermediates, and Fluorine Intermediates. These products serve diverse applications, spanning industries from pharmaceuticals to packaging and extending to agrochemicals, along with paints, coatings, and dyes. With local presence in Europe and China, the Company has a strong presence in the international markets.
Since its inception, the company has maintained a constant focus on quality, innovation, sustainability, customer centricity which has enabled it to become a reliable partner for its customers.
Laxmi Organic

78th STLE Annual Meeting

Not Confirmed

envelop Contact Supplier
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Besylate
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in deliveri...
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in deliveri...
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals. At Aurore, we aim to push the boundaries to manufacture and deliver high quality products that can be relied upon by both customers and regulators. Our thrust on rapidly adding capabilities have led us to acquire, integrate and expand our reach across the geographies.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over ...
Cadila Pharmaceuticals Ltd. is one of the largest privately-held pharmaceutical companies in India. Over the past six decades, we have been developing and manufacturing affordable medicines for patients around the world. Our innovation-led drug discovery processes ensure the health and well-being of people around the world. Our enhanced investment in innovation and a strong track record in research and development have produced medical miracles that have changed lives and made a profound impact on real life.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
3891-07-4
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
3891-07-4
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-42-9
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Mesylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
103129-82-4
Amlodipine Besylate
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. T...
Lofty Laboratories was founded in 2005 with a focus on creating an impact in pharmaceutics value chain. Today we are a leading pharmaceutical bulk drug manufacturer of Intermediates, Advanced Intermediates. Innovation has been forefront of our approach, powered by highly qualified teams and the use of cutting-edge technology. We are a USFDA-approved (USFDA FEI No: 3014053359) company and are continuously expanding our product portfolio and our business to international markets.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
88150-62-3
Amlodipine Besylate
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufactur...
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY